Xeloda better than colon cancer gold-standard A pre-planned multivariate analysis of the five-year follow-up data from the X-ACT study shows that patients receiving chemotherapy after-surgery to treat colon cancer are more likely to live longer when taking Swiss drug major Roche's...
Xeloda better than colon cancer gold-standard _ Xeloda better than colon cancer gold-standard.
Chemotherapy pill Xeloda found more effective A pre-planned multivariate analysis of the five-year follow-up data shows that patients receiving chemotherapy after-surgery to treat colon cancer, are more likely to live longer when taking the chemotherapy pill Xeloda (capecitabine),...
COMMUNIQUE: PR Newswire: Bowel Cancer Patients Live Longer Taking Xeloda - Analysis Confirms That Oral Xeloda is Superior to IV 5-FU - Not for US Media A pre-planned multivariate analysis of the five-year follow-up data shows that patients receiving chemotherapy after-surgery to treat colon cancer, are more...
Glaxo gets formal EU okay for breast cancer drug LONDON (Reuters) - GlaxoSmithKline Plc has received formal European marketing authorisation for its new breast cancer pill Tyverb, the drugmaker said on Thursday.The green light from the European Commission, granting the medicine a...
GSK's Tyverb granted conditional licence in EU European regulators have given GlaxoSmithKline's Tyverb conditional approval, clearing it for launch but asking for more clinical data.Tyverb (lapatinib) was originally approved by the EMEA earlier this year, but concerns over liver side...
GSK's Tyverb granted conditional licence in EU European regulators have given GlaxoSmithKline's Tyverb conditional approval, clearing it for launch but asking for more clinical data.Tyverb (lapatinib) was originally approved by the EMEA earlier this year, but concerns over liver side...
Pharsight to Present on Oncology Modeling and Simulation at PAGE Annual Meeting Laurent Claret Will Present Case Studies on the Value of Drug-Disease Modeling to Predict Efficacy and Survival Benefits of Anticancer Agents MOUNTAIN VIEW, Calif., June 12, 2008 /PRNewswire-FirstCall/ -- Pharsight Corporation , a leading...
ASCO: Biologics Work Synergistically Against Metastatic Breast Cancer if Trastuzumab Regimens Fail Bloom with Breastcancer.org this spring by supporting the care until the cure.Learn more ASCO: Biologics Work Synergistically Against Metastatic Breast Cancer if Trastuzumab Regimens Fail What breastcancer.org says about this article The...
Roche breast cancer pill fails to help older women Bloom with Breastcancer.org this spring by supporting the care until the cure.Learn more What breastcancer.org says about this article Xeloda (chemical name: capecitabine) is a chemotherapy medicine that has been shown to be a good...
Roche breast cancer pill fails to help older women CHICAGO (Reuters) - Swiss drugmaker Roche Holding AG's oral chemotherapy drug Xeloda, or capecitabine, proved inferior to standard chemotherapy in treating older women with early stage breast cancer, a study released on Saturday at a...
Conventional Chemotherapy Outperforms Xeloda in Older Breast Cancer Patients _ Conventional Chemotherapy Outperforms Xeloda in Older Breast Cancer Patients.
ASCO: Capecitabine Inferior to Older Chemotherapy for Older Breast Cancer Patients CHICAGO, June 3 -- Older patients with early-stage breast cancer have a reduced risk of relapse when treated with conventional adjuvant chemotherapy than with capecitabine (Xeloda), according to findings from a randomized, multicenter...
Data Confirm Avastin(R) Helps Patients With Metastatic Colorectal Cancer Live Even LongerX/font] Data Confirm Avastin(R) Helps Patients With Metastatic Colorectal Cancer Live Even Longer - Thousands Of Patients Benefit Provided From Avastin-Based Therapy A wealth of new Avastin (bevacizumab) data will be presented at the 44th annual...
Data Confirm Avastin(R) Helps Patients With Metastatic Colorectal Cancer Live Even Longer Thousands Of Patients Benefit Provided From Avastin-Based Therapy BASEL, Switzerland, May 31 (HSMN NewsFeed) -- A wealth of new Avastin (bevacizumab) data will be presented at the 44th annual meeting of the American Society of Clinical...
New Data from Several Satraplatin Clinical Trials in Solid Tumors Presented at 44th ASCO Annual Meeting , 4:05 AM EST News source: Business Wire GPC Biotech AG (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) today announced the presentation of data from several satraplatin clinical trials at the 44th Annual Meeting of the American Society for...
Study: Herceptin benefits patients with metastatic HER2-positive breast cancer New data from two studies show that additional treatment with Roche's Herceptin (trastuzumab) benefited women with metastatic HER2-positive breast cancer who had seen their disease progress during previous therapy with the drug, the company...
Roche breast cancer pill fails to help older women CHICAGO, May 31 (Reuters) - Swiss drugmaker Roche Holding AG's (ROG.VX: Quote, Profile, Research) oral chemotherapy drug Xeloda, or capecitabine, proved inferior to standard chemotherapy in treating older women with early stage breast...
COMMUNIQUE: PR Newswire: Data Confirm Avastin(R) Helps Patients With Metastatic Colorectal Cancer Live Even Lo - Thousands Of Patients Benefit Provided From Avastin-Based Therapy A wealth of new Avastin (bevacizumab) data will be presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago confirming that...
Data Confirm Avastin(R) Helps Patients With Metastatic Colorectal Cancer Live Even Longer BASEL, Switzerland, May 31 /CNW/ - A wealth of new Avastin (bevacizumab) data will be presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago confirming that Avastin-based therapy is essential for...
Data Confirm Avastin(R) Helps Patients With Metastatic Colorectal Cancer - Thousands Of Patients Benefit Provided From Avastin-Based Therapy A wealth of new Avastin (bevacizumab) data will be presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago confirming that...
Roche says Herceptin with Pertuzumab 'impressive' ZURICH (Reuters) - Roche Holding AG's Herceptin combined with pertuzumab showed 'impressive results' in a phase II breast cancer trial, the Swiss drugmaker said on Friday.The company also cited a late-stage trial showing that Herceptin...
Roche breast cancer pill fails to help older women CHICAGO (Reuters) - Swiss drugmaker Roche Holding (other-otc: RHHBY.PK - news - people ) AG's oral chemotherapy drug Xeloda, or capecitabine, proved inferior to standard chemotherapy in treating older women with early stage breast...
Herceptin Prolongs Progression Free Survival Of HER2 Breast Cancer Patients Breast Cancer News Featured Article Main Category: Breast Cancer Also Included In: Pharma Industry / Biotech Industry; Clinical Trials / Drug Trials email to a friend printer friendly view / write opinions rate article Current Article...
COMMUNIQUE: PR Newswire: Continuing Herceptin Treatment Prevents Disease Progression in Women With Aggressive - Women With HER2-Positive Breast Cancer Benefit From Nearly Three Extra Months of Life Without Progression BASEL, Switzerland, May 30 /PRNewswire/ -- New data presented at the American Society for Clinical Oncology Annual Meeting (ASCO)...
